Zhenfa Zhang

Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer

Xiaoyan Sun, Weiran Liu, Leina Sun et al. · Journal for ImmunoTherapy of Cancer · 2022 · 134 citations · Full text

Medicine, Oncology, Pathology +17

Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma

Dingli Wang, Guangyao Zhou, Shuai Jiang et al. · Journal for ImmunoTherapy of Cancer · 2025 · 74 citations · Full text

Medicine, Immunology, Oncology +17

Leveraging mitochondrial-programmed cell death dynamics to enhance prognostic accuracy and immunotherapy efficacy in lung adenocarcinoma

Lianmin Zhang, Yanan Cui, Guangyao Zhou et al. · Journal for ImmunoTherapy of Cancer · 2024 · 72 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Development and validation of a survival model for lung adenocarcinoma based on autophagy-associated genes

Xiaofei Wang, Shuang Yao, Zengtuan Xiao et al. · Journal of Translational Medicine · 2020 · 65 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non–Small-Cell Lung Cancer

Dongsheng Yue, Shidong Xu, Qun Wang et al. · Journal of Clinical Oncology · 2022 · 63 citations

Medicine, Oncology, Pharmacology +16